Cargando…

Alternating Electric Fields (TTFields) Activate Ca(v)1.2 Channels in Human Glioblastoma Cells

Tumor treating fields (TTFields) represent a novel FDA-approved treatment modality for patients with newly diagnosed or recurrent glioblastoma multiforme. This therapy applies intermediate frequency alternating electric fields with low intensity to the tumor volume by the use of non-invasive transdu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuhaus, Eric, Zirjacks, Lisa, Ganser, Katrin, Klumpp, Lukas, Schüler, Uwe, Zips, Daniel, Eckert, Franziska, Huber, Stephan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356873/ https://www.ncbi.nlm.nih.gov/pubmed/30669316 http://dx.doi.org/10.3390/cancers11010110

Ejemplares similares

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study
por: Zirjacks, Lisa, et al.
Publicado: (2021)

Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

Ion channels as molecular targets of glioblastoma electrotherapy
por: Abed, Tayeb, et al.
Publicado: (2023)

hERG K(+) Channels Promote Survival of Irradiated Leukemia Cells
por: Palme, Daniela, et al.
Publicado: (2020)

Ion Channels in Brain Metastasis
por: Klumpp, Lukas, et al.
Publicado: (2016)

Reply to the Letter to the Editor by D. D’Arcangelo et al.: “Ion Channels in Brain Metastasis”—Ion Channels in Cancer Set up and Metastatic Progression Ion Channels in Brain Metastasis
por: Klumpp, Lukas, et al.
Publicado: (2017)

TRPM8 is required for survival and radioresistance of glioblastoma cells
por: Klumpp, Dominik, et al.
Publicado: (2017)

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
por: Kirson, Eilon D, et al.
Publicado: (2009)

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
por: Kirson, Eilon D., et al.
Publicado: (2009)

BK K(+) channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells
por: Edalat, Lena, et al.
Publicado: (2016)

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])
por: Shams, Shadi, et al.
Publicado: (2022)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report
por: Ding, Yuxuan, et al.
Publicado: (2023)

Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo
por: Voloshin, Tali, et al.
Publicado: (2016)

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K(Ca)3.1 K(+) Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction
por: Stransky, Nicolai, et al.
Publicado: (2022)

Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
por: Stransky, Nicolai, et al.
Publicado: (2023)

Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays
por: Li, Xing, et al.
Publicado: (2022)

Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
por: Li, Shupeng, et al.
Publicado: (2022)

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
por: Nickl, Vera, et al.
Publicado: (2022)

An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields
por: Tuszynski, Jack A., et al.
Publicado: (2016)

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
por: Eckert, Franziska, et al.
Publicado: (2019)

Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study
por: Straube, Christoph, et al.
Publicado: (2018)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
por: Ballo, Matthew T., et al.
Publicado: (2023)

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment
por: Lee, Yeon-Joo, et al.
Publicado: (2020)

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis
por: Berkelmann, Lukas, et al.
Publicado: (2019)

Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment
por: Gentilal, Nichal, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
por: Vergote, Ignace, et al.
Publicado: (2023)

Ionizing radiation, ion transports, and radioresistance of cancer cells
por: Huber, Stephan M., et al.
Publicado: (2013)

COVD-04. REAL-WORLD PERSPECTIVES: TUMOR TREATING FIELDS (TTFIELDS) UTILITY TO OPTIMIZE TREATMENT OF PATIENTS WITH GLIOBLASTOMA (GBM) AMIDST COVID-19 PANDEMIC
por: Frongillo, Peggy, et al.
Publicado: (2020)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

Computed modeling of alternating electric fields therapy for recurrent glioblastoma
por: Lok, Edwin, et al.
Publicado: (2015)

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
por: Guberina, N., et al.
Publicado: (2020)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpmbq9i47r78od4tv3ps4r8v8t